06/23 .2021
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
08/02 .2021
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
08/04 .2021
Shenzhen Kangtai says vaccine effective against Delta variant
Shenzhen Kangtai says vaccine effective against Delta variant
09/06 .2021
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
11/03 .2021
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
11/18 .2021
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
Copyright © 1992-2024 Shenzhen Kangtai Biological Products Co., Ltd.
